detinfДЕТСКИЕ ИНФЕКЦИИCHILDREN INFECTIONS2072-81072618-8139Association of Pediatricians and Infection Disease doctors10.22627/2072-8107-2018-17-3-68-71detinf-381Research ArticleСЛУЧАЙ ИЗ ПРАКТИКИCASE FROM PRACTICALКЛИНИЧЕСКИЙ СЛУЧАЙ ПОРАЖЕНИЯ КОЖИ ПРИ ПАРВОВИРУСНОЙ ИНФЕКЦИИCLINICAL CASE OF SKIN LESIONS WITH PARVOVIRUS B19 INFECTIONИльенкоЛ. И.IlienkoL. I.

Ильенко Лидия Ивановна – доктор медицинских наук, профессор, заведующая кафедрой госпитальной педиатрии №2 педиатрического факультета РНИМУ им. Н.И. Пирогова МЗ РФ.

Москва.

Lidiya I. Ilienko.

Moscow.

https://orcid.org/0000-0003-4548-8778ПашинянА. Г.PashinyanA. G.

Пашинян  Альбина  Гургеновна - доктор медицинских наук, профессор  кафедры дерматовенерологии  лечебного факультета  РНИМУ им. Н.И. Пирогова МЗ РФ.

Москва.

Albina G. Pashinyan - MD, PhD, Professor of the Department of Dermatovenereology  of the Medical Faculty.

Moscow.

stsoagp4@gmail.comhttps://orcid.org/0000-0002-6090-9676ВасеноваВ. Ю.VasenovaV. Yu.

Васенова  Виктория Юрьевна - доктор медицинских наук, профессор кафедры кожных болезней и косметологии  РНИМУ им. Н.И. Пирогова МЗ РФ.

Москва.

Viktoria Yu. Vasenova.

Moscow.

Российский национальный исследовательский медицинский университет им. Н.И. Пирогова МЗ РФРоссияPirogov Russian National Research Medical UniversityRussian Federation2018210920181736871Copyright © Ильенко Л.И., Пашинян А.Г., Васенова В.Ю., 20182018Ильенко Л.И., Пашинян А.Г., Васенова В.Ю.Ilienko L.I., Pashinyan A.G., Vasenova V.Y.This work is licensed under a Creative Commons Attribution 4.0 License.https://detinf.elpub.ru/jour/article/view/381

Представлена клинико-эпидемиологическая характеристика парвовирусной В19 инфекции. Особо опасен вирус для беременных женщин в I и II триместрах беременности, так как может приводить к спонтанным абортам, развитию неиммунной водянки или внутриутробной гибели плода. Для инфекционной эритемы характерна яркая эритема кожи  щек — симптом «отшлепанных» щек, пятнисто-папулезная «кружевная» сыпь на коже туловища и разгибательных поверхностей конечностей, чаще встречающаяся у детей в возрасте от 4 до 10 лет. Диагностика парвовирусной инфекции В19 основана на результатах серологических методов, ПЦР, обнаружения IgM, иммуноблота IgM/IgG. Описан клинический случай инфекционной эритемы у девочки 5 лет.

Clinico-epidemiological characteristics of parvovirus В19 infection are presented. Especially dangerous is the virus for pregnant women in the first and second trimesters of pregnancy, as it can lead to spontaneous abortion, the development of non-immune dropsy or intrauterine fetal death. Infectious erythema is characterized by a bright erythema of the cheek skin — a symptom of «spanked» cheeks, a patchy-papular «lacy» rash on the skin of the trunk and extensor surfaces of the extremities, more common in children aged 4 to 10 years. Diagnosis of parvovirus infection B19 is based on the results of serological methods, PCR, detection of IgM, immunoblot IgM/IgG. A clinical case of infectious erythema in a girl of 5 years is described.

инфекционная эритемапарвовирус В19infectious erythemaparvovirus B19ReferencesCossart Y.E., Field A.M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet .1975;11(1):72—3.Cossart Y.E., Field A.M., Cant B., Widdows D. Parvovirus-like particles in human sera. Lancet .1975;11(1):72—3.Candotti D., Etiz N., Parsyan A., Allain J.P. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol .2004; 78(22):12169—78.Candotti D., Etiz N., Parsyan A., Allain J.P. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol .2004; 78(22):12169—78.Parsyan A,. Szmaragd C., Allain J.P., Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol .2007; 88( 2):428—31.Parsyan A,. Szmaragd C., Allain J.P., Candotti D. Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol .2007; 88( 2):428—31.Filippone C., Zhi N., Wong S., Lu J., Kajigaya S., Gallinella G., Kakkola L., Söderlund-Venermo M., Young N.S., Brown KE.VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology. 2010; 374(2):444-52. doi: 10.1016/j.virol.2008.01.002Filippone C., Zhi N., Wong S., Lu J., Kajigaya S., Gallinella G., Kakkola L., Söderlund-Venermo M., Young N.S., Brown KE.VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones. Virology. 2010; 374(2):444-52. doi: 10.1016/j.virol.2008.01.002Anderson L.J., Tsou C., Parker R.A., Chorba T.L., Wulff H., Tattersall P., Mortimer P.P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986; 24:522—6.Anderson L.J., Tsou C., Parker R.A., Chorba T.L., Wulff H., Tattersall P., Mortimer P.P. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol. 1986; 24:522—6.Marano G., Vaglio S., Pupella S., Facco G., Calizzani G., Candura F., Liumbruno G.M, Grazzini G. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus. 2015;13(2):184—196. doi:10.2450/2014.0174.14Marano G., Vaglio S., Pupella S., Facco G., Calizzani G., Candura F., Liumbruno G.M, Grazzini G. Human Parvovirus B19 and blood product safety: a tale of twenty years of improvements. Blood Transfus. 2015;13(2):184—196. doi:10.2450/2014.0174.14Lamont R.F., Sobel J.D., Vaisbuch E., Kusanovic J.P., Mazaki-Tovi S., Kim S.K., Uldbjerg N., Romero R. Parvovirus B19 infection in human pregnancy. BJOG. 2011;118(2):175—86.Lamont R.F., Sobel J.D., Vaisbuch E., Kusanovic J.P., Mazaki-Tovi S., Kim S.K., Uldbjerg N., Romero R. Parvovirus B19 infection in human pregnancy. BJOG. 2011;118(2):175—86.Subtil D., Garabedian C., Chauvet A. Parvovirus B19 infection and pregnancy. Presse Med. 2015; 44(6):647—53. doi: 10.1016Subtil D., Garabedian C., Chauvet A. Parvovirus B19 infection and pregnancy. Presse Med. 2015; 44(6):647—53. doi: 10.1016Enders M., Klingel K., Weidner A., Baisch C., Kandolf R., Schalasta G., Enders G. Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2010; 49(3):163—8. doi: 10.1016/j.jcv.2010.07.014Enders M., Klingel K., Weidner A., Baisch C., Kandolf R., Schalasta G., Enders G. Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2010; 49(3):163—8. doi: 10.1016/j.jcv.2010.07.014Shabani Z., Esghaei M., Keyvani H., Shabani F., Sarmadi F., Mollaie H., Monavari S.H. Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med J Islam Repub Iran. 2015; 7(29):197.Shabani Z., Esghaei M., Keyvani H., Shabani F., Sarmadi F., Mollaie H., Monavari S.H. Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med J Islam Repub Iran. 2015; 7(29):197.Ugai S., Aizawa Y., Kanayama T., Saitoh A. Parvovirus B19: A Cause of Sepsislike Syndrome in an Infant. Pediatrics. 2018; 141(6). pii: e20171435. doi: 10.1542/peds.2017—1435.Ugai S., Aizawa Y., Kanayama T., Saitoh A. Parvovirus B19: A Cause of Sepsislike Syndrome in an Infant. Pediatrics. 2018; 141(6). pii: e20171435. doi: 10.1542/peds.2017—1435.Сидорова И.С., Кулаков В.И., Макаров И.О. Руководство по акушерству. М.: Медицина, 2006: 362.Sidorova I.S., Kulakova V.I., Makarov I.O. Guide to Midwifery Moscow: Meditcina, 2006: 362. (In Russ.)Пашинян А.Г., Рунихина Н.К., Мокеева Е.Ю. Инфекционная эритема: клинический случай. Росс журнал кожн и венер болезней. 2016;19(4):206—209.Pashinyan A.G., Runikhina N.A., Mokeeva E.Yu. Erytema infectiosum: clinical case. Rossiyskiy Zhurnal Kozhnykh i Venericheskikh Bolezney = Russian Journal of Skin and Venereal Disease 2016;19(4):206—209. (In Russ.) https://doi.org/:10.18821/1560-9588-2016-19-4-206-209Gustafsson I., Kaldensjö T., Lindblom A., Norbeck O., Henter J.I., Tolfvenstam T., Broliden K. Evaluation of parvovirus B19 infection in children with malignant or hematological disorders. Clin. Infect. Dis. 2010; 50(10):1426—7 doi: 10.1086/652286.Gustafsson I., Kaldensjö T., Lindblom A., Norbeck O., Henter J.I., Tolfvenstam T., Broliden K. Evaluation of parvovirus B19 infection in children with malignant or hematological disorders. Clin. Infect. Dis. 2010; 50(10):1426—7 doi: 10.1086/652286.Dingli D., Pfizenmaier D.H., Arromdee E., Wennberg P., Spittell P.C., Chang-Miller A., Clarke B.L. Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet. 2000; 356:312—314. doi: 10.1016/S0140-6736(00)02512—5.Dingli D., Pfizenmaier D.H., Arromdee E., Wennberg P., Spittell P.C., Chang-Miller A., Clarke B.L. Severe digital arterial occlusive disease and acute parvovirus B19 infection. Lancet. 2000; 356:312—314. doi: 10.1016/S0140-6736(00)02512—5.Kerr J.R. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann. Rheum. Dis. 2000; 59:672—683. doi: 10.1136/ard.59.9.672.Kerr J.R. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann. Rheum. Dis. 2000; 59:672—683. doi: 10.1136/ard.59.9.672.Bock C.T., Düchting A., Utta F., Brunner E., Sy B.T., Klingel K., Lang F., Gawaz M., Felix S.B., Kandolf R. Molecular phenotypes of human parvovirus B19 in patients with myocarditis. World J Cardiol. 2014; 26;6(4):183—95. doi: 10.4330/wjc.v6.i4.183.Bock C.T., Düchting A., Utta F., Brunner E., Sy B.T., Klingel K., Lang F., Gawaz M., Felix S.B., Kandolf R. Molecular phenotypes of human parvovirus B19 in patients with myocarditis. World J Cardiol. 2014; 26;6(4):183—95. doi: 10.4330/wjc.v6.i4.183.Tesapirat L., Wanlapakorn N., Chieochansin T., Poovorawan Y. Parvovirus b19 infection presenting as acute hepatitis and transient anemia in a previously healthy child. Southeast Asian J Trop Med Public Health. 2015; 46(2):226—30.Tesapirat L., Wanlapakorn N., Chieochansin T., Poovorawan Y. Parvovirus b19 infection presenting as acute hepatitis and transient anemia in a previously healthy child. Southeast Asian J Trop Med Public Health. 2015; 46(2):226—30.Valencia Pacheco G., Nakazawa Ueji Y.E., Rodríguez Dzul E.A., Angulo Ramírez A.V., López Villanueva R.F., Quintal Ortiz I.G., Rosado Paredes EP. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. Colomb Med (Cali). 2017; 48(3):105—112. doi: 10.25100/cm.v48i3.2981.Valencia Pacheco G., Nakazawa Ueji Y.E., Rodríguez Dzul E.A., Angulo Ramírez A.V., López Villanueva R.F., Quintal Ortiz I.G., Rosado Paredes EP. Serological and molecular analysis of parvovirus B19 infection in Mayan women with systemic lupus erythematosus in Mexico. Colomb Med (Cali). 2017; 48(3):105—112. doi: 10.25100/cm.v48i3.2981.Peterlana D., Puccetti A., Corrocher R., Lunardi C. Serologic and molecular detection of human parvovirus B19 infection. Clin Chim Acta. 2006; 372:14—23.Peterlana D., Puccetti A., Corrocher R., Lunardi C. Serologic and molecular detection of human parvovirus B19 infection. Clin Chim Acta. 2006; 372:14—23.Koppelman M.H., van Swieten P., Cuijpers H.T. Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Transfusion. 2011; 51(6):1346—54. doi: 10.1111.Koppelman M.H., van Swieten P., Cuijpers H.T. Real-time polymerase chain reaction detection of parvovirus B19 DNA in blood donations using a commercial and an in-house assay. Transfusion. 2011; 51(6):1346—54. doi: 10.1111.Juhl D., Gorg S., Hennig H. Persistence of parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors. Vox Sang. 2014; 107:226—232.Juhl D., Gorg S., Hennig H. Persistence of parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors. Vox Sang. 2014; 107:226—232.Nadimpalli S.S., Miller R.S., Kamath V.M., Farkouh C.R., NhanChang C.L., Rathe J.A.,, Collins A., Duchon J.M., Neu N., Simpson L.L., Ratner A.J. Congenital Parvovirus B19 Infection: Persistent Viremia and Red Blood Cell Aplasia. Open Forum Infect Dis. 2015; 2(2):049. doi:10.1093/ofid/ofv049Nadimpalli S.S., Miller R.S., Kamath V.M., Farkouh C.R., NhanChang C.L., Rathe J.A.,, Collins A., Duchon J.M., Neu N., Simpson L.L., Ratner A.J. Congenital Parvovirus B19 Infection: Persistent Viremia and Red Blood Cell Aplasia. Open Forum Infect Dis. 2015; 2(2):049. doi:10.1093/ofid/ofv049Bonvicini F., Puccetti C., Salfi N.C., Guerra B., Gallinella G., Rizzo N., Zerbini M. Gestational and Fetal Outcomes in B19 Maternal Infection: a Problem of Diagnosis. J Clin Microbiol. 2011; 49(10):3514—3518. doi: 10.1128/JCM.00854-11Bonvicini F., Puccetti C., Salfi N.C., Guerra B., Gallinella G., Rizzo N., Zerbini M. Gestational and Fetal Outcomes in B19 Maternal Infection: a Problem of Diagnosis. J Clin Microbiol. 2011; 49(10):3514—3518. doi: 10.1128/JCM.00854-11

The authors declare that there are no conflicts of interest present.